Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey

BACKGROUND: Durvalumab as maintenance treatment after platinum-based concurrent chemoradiotherapy (cCRT) has become the standard of care in inoperable stage III non-small cell lung cancer (NSCLC). In this nationwide survey, we solicited members of the German Radiation Oncology Society to review the...

Descripción completa

Detalles Bibliográficos
Autores principales: Käsmann, Lukas, Eze, Chukwuka, Taugner, Julian, Roengvoraphoj, Olarn, Belka, Claus, Manapov, Farkhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225149/
https://www.ncbi.nlm.nih.gov/pubmed/32420068
http://dx.doi.org/10.21037/tlcr.2020.03.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225149/
https://www.ncbi.nlm.nih.gov/pubmed/32420068
http://dx.doi.org/10.21037/tlcr.2020.03.25

Ejemplares similares